C E M Griffiths Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

08/2008	Methotrexate for psoriasis in the era of biological therapy.
05/2008	Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis.
11/2006	The role of neuropeptides in psoriasis.
06/2006	Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
02/2006	Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
12/2005	Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
11/2005	The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasis.
09/2005	Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
06/2005	Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis.
06/2005	A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
06/2005	Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
01/2005	Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
07/2004	Streptococcal infection may make psoriasis worse but do antibiotics help?
05/2004	Ciclosporin in psoriasis clinical practice: an international consensus statement.
01/2003	Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis.
10/2002	Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis.
05/2002	Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.
03/2002	Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis.

Articles by Research Topic

Disease

18	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2008 - 03/2002
2	Psoriatic Arthritis 05/2008 - 03/2005
1	Arthritis (Polyarthritis) 05/2008
1	Skin Diseases 07/2006
1	Hidradenitis Suppurativa 05/2006
1	Pyoderma Gangrenosum 04/2006
1	Streptococcal Infections (Streptococcal Infection) 07/2004
1	Oral Lichen Planus 01/2003
1	Atopic Dermatitis (Atopic Eczema) 08/2002
1	Inflammation 01/2002

Drug/Important Bio-Agent (IBA)

2	Methotrexate (Mexate)FDA LinkGeneric 08/2008 - 11/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2006 - 05/2004
2	infliximab (Remicade)FDA Link 06/2006 - 04/2006
2	TNFR-Fc fusion protein (etanercept)FDA Link 12/2005 - 06/2005
1	HLA-DRB1 antigen (HLA DRB1)IBA 05/2008
1	NeuropeptidesIBA 11/2006
1	Clindamycin (Cleocin)FDA LinkGeneric 05/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 05/2006
1	ApolipoproteinsIBA 02/2006
1	Acitretin FDA Link 02/2006
1	FumaratesIBA 09/2005
1	pimecrolimus (Elidel)FDA Link 06/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2005
1	alefacept (Amevive)FDA Link 01/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2004
1	Interleukin-8 (Interleukin 8)IBA 01/2003
1	Chemokine CCL5IBA 01/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2003
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2003
1	CalciumIBA 01/2003
1	Caveolin 1IBA 10/2002
1	hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric 08/2002
1	cipamfyllineIBA 08/2002
1	E-SelectinIBA 05/2002
1	1 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA 03/2002
1	CytokinesIBA 01/2002
1	LactoferrinIBA 01/2002

Therapy/Procedure

1	Biological Therapy 08/2008
1	Lasers (Laser) 06/2005